Gene · 55801
Papers1,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26. | J Exp Med | 2024 | 38448036 | PubTator, text mining | PubMed |
| Current Views about the Inflammatory Damage Triggered by Bacterial Superantigens and Experimental Attempts to Neutralize Superantigen-Mediated Toxic Effects with Natural and Biological Products. | Pathophysiology | 2024 | 38251046 | PubTator, text mining | PubMed |
| Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma. | EBioMedicine | 2024 | 38244291 | PubTator, text mining | PubMed |
| IL-26 Potentiates Type 2 Skin Inflammation in the Presence of IL-1β. | J Invest Dermatol | 2024 | 38237730 | PubTator, text mining | PubMed |
| Immunobiology of IL-26. | J Invest Dermatol | 2024 | 38206272 | PubTator, text mining | PubMed |
| Clinical Relevance of Vaginal and Endometrial Microbiome Investigation in Women with Repeated Implantation Failure and Recurrent Pregnancy Loss. | Int J Mol Sci | 2024 | 38203793 | PubTator, text mining | PubMed |
| A radiomics and genomics-derived model for predicting metastasis and prognosis in colorectal cancer. | Carcinogenesis | 2024 | 38195111 | PubTator, text mining | PubMed |
| Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection. | Front Immunol | 2023 | 38288121 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Virus infection pattern imprinted and diversified the differentiation of T-cell memory in transcription and function. | Front Immunol | 2023 | 38264657 | PubTator, text mining | PubMed |
| Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases. | Front Immunol | 2023 | 38239346 | PubTator, text mining | PubMed |
| Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets. | Front Immunol | 2023 | 38239345 | PubTator, text mining | PubMed |
| Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review. | World J Hepatol | 2023 | 38223416 | PubTator, text mining | PubMed |
| How Do Classical Subtypes Correspond to Endotypes in Atopic Dermatitis? | Int J Mol Sci | 2023 | 38203432 | PubTator, text mining | PubMed |
| The Role of IL-23 Inhibitors in Crohn's Disease. | J Clin Med | 2023 | 38202231 | PubTator, text mining | PubMed |
| Modulation of Suppressive Activity and Proliferation of Human Regulatory T Cells by Splice-Switching Oligonucleotides Targeting FoxP3 Pre-mRNA. | Cells | 2023 | 38201281 | PubTator, text mining | PubMed |
| Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models. | Front Immunol | 2023 | 38179052 | PubTator, text mining | PubMed |
| A Multidisciplinary Approach to Patients with Psoriasis and a History of Malignancies or On-Treatment for Solid Tumors: A Narrative Literature Review. | Int J Mol Sci | 2023 | 38139369 | PubTator, text mining | PubMed |
| A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. | Biomedicines | 2023 | 38137450 | PubTator, text mining | PubMed |
| Xenophagy as a Strategy for Mycobacterium leprae Elimination during Type 1 or Type 2 Leprosy Reactions: A Systematic Review. | Pathogens | 2023 | 38133338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55801/papers?page=5